ESR1 and breast carcinoma: Interestingly, AR signaling in ER+ breast cancer is thought to be associated with favorable prognosis (114, 115), and the reduction of HIPK3 and NCOA4 may negatively affect AR signaling and ER+ breast cancer prognosis.